Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluciclovine PET for High Grade Glioma Recurrence
NCT05479136Phase 3Unknown
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluciclovine f 18 in high-grade glioma (HGG). Status: unknown.
02
Drugs
fluciclovine f 18
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT05479136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05479136.